Clal Biotechnology Industries
Venture capitalTel Aviv · Seed–Late Stage · 8 people tracked
Investment thesis
CBI concentrates on the life sciences sector, backing companies that develop proprietary solutions addressing unmet medical needs with significant market potential. It builds and oversees a global portfolio of innovative healthcare ventures, aiming to advance treatments worldwide. As a publicly listed investment firm, CBI identifies and nurtures groundbreaking science-driven businesses from an early stage through their development.
Source: firm website, verified Aug 3, 2026.
Team · 8 people
from the firm's website & public directories_edited.jpg)
What they invest in
from 7 of 8 portfolio companiesHealthtech ×5Biotech ×4AI & Machine Learning ×2Digital Health ×2Hardware ×2Medical Devices ×2
Investments · 8 tracked
founders shown can be your intro pathBiotechYavne
Ety Klinger(Executive Officer, Director)Ofer Gonen(Executive Officer)Boaz Gur-Lavie(Chief Financial Officer)Sharon Malka(Director)Vickie R. Driver(Director)Tzvi Palash(Executive Officer)
PartnerAvi Fischer· solo GP
Biokine Therapeutics is a private biopharmaceutical company developing cancer therapeutics targeting tumor migration, survival, and immune-response pathways; its lead product BKT140/BL8040 is a CXCR4 receptor inhibitor used for stem cell mobilization and cancer immunotherapy.
BiotechHealthtech
PartnerAvi Fischer· solo GP
Colospan develops CG-100, a CE-marked intraluminal bypass device made of soft silicone that is placed through the anus to protect the surgical site after colorectal surgery, serving as an alternative to a diverting stoma.
HardwareHealthtechMedical Devices
PartnerAvi Fischer· solo GP
Elicio develops cancer immunotherapies including vaccines, immunomodulators, and adjuvants built on its lymph node-targeted AMP platform to activate and amplify cancer-fighting T cells.
BiotechHealthtech
PartnerAvi Fischer· solo GP
FDNA develops AI-powered image analysis and decision-support tools that help parents, school nurses, and pediatric and genetic specialists detect developmental delays, genetic disorders, and rare diseases earlier.
AI & Machine LearningDigital HealthHealthtech
PartnerAvi Fischer· solo GP
Pi-Cardia develops non-implant-based, catheter-delivered devices for treating structural heart disease, including its ShortCut product for leaflet modification.
HardwareHealthtechMedical Devices
PartnerAvi Fischer· solo GP
Sight develops immune signatures by analyzing live immune cells using AI to generate clinical insights.
AI & Machine LearningBiotechDigital Health
Ben Leshem(Chief Technology Officer)Nitsan Maayan-Rabinowich(Chief Executive Officer)Asi Cohen-Dotan(Chief Product & Clinical Officer)
PartnerAvi Fischer· solo GP
PartnerAvi Fischer· solo GP
Exits · 1
IPOs and acquisitions across the tracked portfolioMediwoundNASDAQ: MDWD
Frequently asked questions
- What stage does Clal Biotechnology Industries invest at?
- Clal Biotechnology Industries invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does Clal Biotechnology Industries focus on?
- Clal Biotechnology Industries focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Clal Biotechnology Industries located?
- Clal Biotechnology Industries is headquartered in Tel Aviv, IL.
Images
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
Capricorn Venture Partners is a European investment firm managing several thematic funds across growth capital, healthcare, and cleantech, as well as a combined private/quoted investment vehicle.
The Novartis Venture Fund invests in innovative life science companies, focusing on biotechnology and biopharmaceuticals at various stages of growth, aiming to drive patient benefit and generate returns.
EQT Life Sciences, formerly LSP, is one of Europe's largest and most experienced life sciences investors, backing companies developing therapeutics, medical devices, diagnostics and healthtech globally. It is part of EQT Group.
Portfolia operates thematic venture capital funds designed for women investors, backing companies in areas such as women's health, longevity, active aging, greentech, and fintech, while offering an educational and community-driven investing experience.